Estradiol Transdermal has 10 known drug interactions based on U.S. FDA drug labeling data. Notable interactions include combinations with Carbamazepine, Clarithromycin, Erythromycin. Patients taking Estradiol Transdermal should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 10
- Moderate
- 10
Moderate (10)
- Estradiol Transdermal + Carbamazepine— CYP3A4 inducer that may reduce estradiol plasma concentrations, possibly decreasing therapeutic effects and/or altering …
- Estradiol Transdermal + Clarithromycin— CYP3A4 inhibitor that may increase estradiol plasma concentrations and result in adverse reactions.
- Estradiol Transdermal + Erythromycin— CYP3A4 inhibitor that may increase estradiol plasma concentrations and result in adverse reactions.
- Estradiol Transdermal + Grapefruit Juice— CYP3A4 inhibitor that may increase estradiol plasma concentrations and result in adverse reactions.
- Estradiol Transdermal + Itraconazole— CYP3A4 inhibitor that may increase estradiol plasma concentrations and result in adverse reactions.
- Estradiol Transdermal + Ketoconazole— CYP3A4 inhibitor that may increase estradiol plasma concentrations and result in adverse reactions.
- Estradiol Transdermal + Phenobarbital— CYP3A4 inducer that may reduce estradiol plasma concentrations, possibly decreasing therapeutic effects and/or altering …
- Estradiol Transdermal + Rifampin— CYP3A4 inducer that may reduce estradiol plasma concentrations, possibly decreasing therapeutic effects and/or altering …
- Estradiol Transdermal + Ritonavir— CYP3A4 inhibitor that may increase estradiol plasma concentrations and result in adverse reactions.
- Estradiol Transdermal + St. John'S Wort— CYP3A4 inducer that may reduce estradiol plasma concentrations, possibly decreasing therapeutic effects and/or altering …